Jpmorgan Chase & CO Cv Rx, Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Cv Rx, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 124,959 shares of CVRX stock, worth $829,727. This represents 0.0% of its overall portfolio holdings.
Number of Shares
124,959
Previous 628,286
80.11%
Holding current value
$829,727
Previous $7.96 Million
80.8%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CVRX
# of Institutions
99Shares Held
16.3MCall Options Held
53.4KPut Options Held
32.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$27.2 Million16.67% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$13.5 Million2.35% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT1.23MShares$8.16 Million1.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.01MShares$6.68 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$5.81 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $137M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...